3 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
that primarily target a variety of nuclear antigens, deposit in tissues and activate complement, resulting in organ damage. In August 2023, we announced … sources in total energy consumption % 82 75 Consumption from nuclear products MWh 0 0 Share of consumption from nuclear sources in total energy
6-K
EX-99.1
GLPG
Galapagos NV
30 Aug 23
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus
6:31am
that primarily target a variety of nuclear antigens, deposit in tissues and activate complement, resulting in organ damage. SLE affects women more frequently
- Prev
- 1
- Next